New drug Opdivo successfully ends lung cancer trial

January 12, 2015 11:18 PM

10 0

A new cancer drug, Opdivo, is working so well that pharmaceutical giant Bristol-Myers Squibb announced Monday it is stopping a trial in lung cancer two years ahead of schedule.

The trial compared Opdivo to Docetaxel, a type of chemo used for patients whose cancers have recurred after treatment. The study, in 234 patients, was the largest trial of the drug in lung cancer.

Read more

To category page

Loading...